In addition, investigations into the anticancer mechanisms of apatinib, a targeted angiogenesis inhibitor, have revealed that it can induce ROS production in lung cancer, suppress Nrf2 and p62 expression, and promote autophagy and apoptotic cell death in non-small cell lung cancer (NSCLC) 123. Here, NFE2L2 is linked to non-small cell lung carcinoma.